Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist
At present, proteomic methods have successfully identified potential biomarkers of urological malignancies, such as prostate cancer (PC), bladder cancer (BC), and renal cell carcinoma (RCC), reflecting different numbers of key cellular processes, including extracellular environment modification, inv...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Urological Association
2020-11-01
|
| Series: | Investigative and Clinical Urology |
| Subjects: | |
| Online Access: | tps://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-539.pdf |